Table 6.

AEs reported as symptoms of ARIA-E per study protocol approach (safety-evaluable population with one post-baseline MRI in OLE)

	Total (N = 291)
Total number of participants with at least one AE reported as symptoms of ARIA-E (eCRF), n (%)	3 (1.4)
Total number of AEs reported as symptoms of ARIA (eCRF), n	3
Dizziness, n (%)	1 (0.5)
Headache, n (%)	1 (0.5)
Somnolence, n (%)	1 (0.5)

AE, adverse event; ARIA, amyloid-related imaging abnormalities; ARIA-E, amyloid-related imaging abnormalities-edema; eCRF, electronic case report form; MRI, magnetic resonance imaging; OLE, open-label extension.